The opposing roles of CD4+ T cells in anti-tumour immunity

92Citations
Citations of this article
170Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cancer immunotherapy focuses mainly on anti-tumour activity of CD8+ cytotoxic T lymphocytes (CTLs). CTLs can directly kill all tumour cell types, provided they carry recognizable antigens. However, CD4+ T cells also play important roles in anti-tumour immunity. CD4+ T cells can either suppress or promote the anti-tumour CTL response, either in secondary lymphoid organs or in the tumour. In this review, we highlight opposing mechanisms of conventional and regulatory T cells at both sites. We outline how current cancer immunotherapy strategies affect both subsets and how selective modulation of each subset is important to maximize the clinical response of cancer patients.

Cite

CITATION STYLE

APA

Ahrends, T., & Borst, J. (2018, August 1). The opposing roles of CD4+ T cells in anti-tumour immunity. Immunology. Blackwell Publishing Ltd. https://doi.org/10.1111/imm.12941

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free